The role of platelets and megakaryocytes in sepsis and ARDS

Gabriel Leung1, Elizabeth A Middleton1,2

  • 1Division of Pulmonary, Department of Internal Medicine, University of Utah, Salt Lake City, Utah, USA.

The Journal of Physiology
|October 19, 2024
PubMed

Insights

Megakaryocytes and platelets are key players in systemic inflammation during infections like sepsis. Understanding their role in lung injury and organ failure is crucial for developing new treatments for critical illnesses.

Area of Science:

  • Immunology
  • Hematology
  • Pathophysiology

Background:

  • Systemic inflammation, including acute respiratory distress syndrome (ARDS) and sepsis, causes significant mortality and morbidity.
  • Despite clinical care improvements, severe cases have high mortality rates (∼40%) and persistent morbidity.
  • Identifying underlying biological mechanisms and drivers of organ failure is essential for therapeutic development.

Purpose of the Study:

  • To review the contribution of megakaryocytes (MKs) and platelets to systemic inflammatory syndromes.
  • To explore the role of MKs, including extramedullary MKs, in sepsis pathogenesis.
  • To examine alterations in platelet transcriptome and function during sepsis.

Main Methods:

  • Literature review focusing on megakaryocytes and platelets in systemic inflammation.
  • Analysis of studies on extramedullary MKs during sepsis.
  • Examination of research on platelet transcriptome and functional changes in sepsis.

Main Results:

  • Megakaryocytes (MKs) and platelets are implicated in the pathogenesis of systemic inflammatory syndromes.
  • Extramedullary MKs have been identified during sepsis, highlighting their role beyond the bone marrow.
  • Sepsis induces significant alterations in the platelet transcriptome and affects platelet function, including aggregation and heterotypic aggregate formation.

Conclusions:

  • Platelets are increasingly recognized as key contributors to inflammation in critical illnesses.
  • Further research is necessary to fully elucidate the complex role of platelets in diverse systemic inflammatory syndromes.
  • Understanding platelet involvement may reveal novel therapeutic targets for sepsis and ARDS.

Related Concept Videos

Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
1.0K
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
4.8K
Introduction to Hemostasis01:05

Introduction to Hemostasis

Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
6.0K
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
124
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
176